New immunotherapy 'highly effective' against hepatitis B
by University College LondonCredit: CC0 Public DomainScientists at UCL have identified a new immunotherapy to combat the hepatitis B virus (HBV), the most common cause of liver cancer in the worl
Updated on: May 06,2024
11
New immunotherapy 'highly effective' against hepatitis B
by University College LondonCredit: CC0 Public DomainScientists at UCL have identified a new immunotherapy to combat the hepatitis B virus (HBV), the most common cause of liver cancer in the worl
Updated on:May 06,2024
11